From: Two Neutralizing Human Anti-RSV Antibodies: Cloning, Expression, and Characterization
No. Cells/Well | No. Wells | Anti-F Wells n (%) | Wells with Growth n (%) |
---|---|---|---|
RF-1 | Â | Â | Â |
30 | 48 | 48 (100) | 48 (100) |
10 | 48 | 48 (100) | 48 (100) |
3.3 | 96 | 27 (28) | 68 (71) |
1.1 | 192 | 17 (9) | 112 (58) |
0.38 | 384 | 18 (5) | 116 (30) |
RF-2 | Â | Â | Â |
30 | 40 | 15 (37.5) | 40 (100) |
10 | 120 | 22 (18) | 120 (100) |
3.3 | 120 | 9 (7.5) | 102 (85) |
1.1 | 120 | 1 (0.83) | 50 (41.6) |
0.33 | 180 | 5 (2.8) | 30 (16.7) |